Programme  Titles  Presenters 
Sunday, 11th February 2018
08:00-11:00  Registration
The David Lopatie Conference Centre
11:00-11:20  Welcome and Introduction
11:20-13:00  Session 1: Cellular and Organismal Homeostasis
The Michael and Anna Wix Auditorium
11:20-12:00  [INV01] Ruslan Medzhitov, Yale University, USA | Homeostasis and inflammation
The Michael and Anna Wix Auditorium
12:00-12:30  [INV02] Julie Magarian Blander, Weill Cornell Medical College, USA | Phagocyte responses to dying cells
The Michael and Anna Wix Auditorium
12:30-13:00  [INV03] Ido Amit, Weizmann Institute of Science, Israel | The power of ONE: Immunology in the age of single cell genomics
The Michael and Anna Wix Auditorium
13:00-14:20  Lunch
The David Lopatie Conference Centre
14:20-16:05  Session 1: Cellular and Organismal Homeostasis cont.
The Michael and Anna Wix Auditorium
14:20-14:35  Human dendritic cells: From development to functions [ST01]
The Michael and Anna Wix Auditorium
14:35-15:05  [INV42] Ramnik Xavier, Broad Institute of MIT and Harvard | Host genetics and barrier function in gut inflammation
The Michael and Anna Wix Auditorium
15:05-15:35  [INV05] Virginia Pascual, Weill Cornell Medical College, USA | Human Lupus: Adding new pieces to the puzzle
The Michael and Anna Wix Auditorium
15:35-16:05  [INV06] Eicke Latz, University of Bonn, Germany | Sensing of cellular dyshomeostasis by inflammasomes
The Michael and Anna Wix Auditorium
16:05-16:35   Refreshment Break
The David Lopatie Conference Centre
16:35-20:20  Session 1: Cellular and Organismal Homeostasis cont.
The Michael and Anna Wix Auditorium
16:35-16:50  [INV07] Yifat Merbl, Weizmann Institute of Science, Israel | Fine-tuning regulation of Golgi apparatus morphology is mediated by Golgi-localized proteasomal degradation
The Michael and Anna Wix Auditorium
16:50-17:05  Spatiotemporal dynamics of naïve CD8+ T cells undergoing intrahepatic priming [ST02]
The Michael and Anna Wix Auditorium
17:05-17:35  [INV08] Fiona Powrie, University of Oxford, UK | Gut reactions: Immune pathways in the intestine in health and disease
The Michael and Anna Wix Auditorium
17:35-17:50  Immunoregulation of microbial-driven liver inflammation [ST06]
The Michael and Anna Wix Auditorium
17:50-18:20  [INV09] David Artis, Weill Cornell Medicine, USA | Immune regulation at barrier surfaces
The Michael and Anna Wix Auditorium
18:20-20:20  Poster session 1
The David Lopatie Conference Centre
18:20-21:30  Drinks Reception and Dinner
 
Monday, 12 February 2018
09:00-10:30  Session 2: Host-microbe Interactions
The Michael and Anna Wix Auditorium
09:00-09:30  [INV10] Pascale Cossart, Institüt Pasteur, France | Intestinal microbiota and infection: The Listeria paradigm
The Michael and Anna Wix Auditorium
09:30-10:00  [INV11] Yasmine Belkaid, NIH, USA | An ancient arm of adaptive immunity controls microbiota impact on skin immunity and tissue repair
The Michael and Anna Wix Auditorium
10:00-10:30  [INV12] Maria Rescigno, IEO European Institute of Oncology, Italy | The gut-liver axis in immunological disorders
The Michael and Anna Wix Auditorium
10:30-11:00  Refreshment Break
The David Lopatie Conference Centre
11:00-12:45  Session 2: Host-microbe Interactions cont.
The Michael and Anna Wix Auditorium
11:00-11:30  [INV13] Eran Elinav, Weizmann Institute of Science, Israel | Host-Microbiome Interactions in Health and Disease
The Michael and Anna Wix Auditorium
11:30-12:00  [INV14] Jorge Henao-Mejia, University of Pennsylvania, USA | RNA regulation of the immune system
The Michael and Anna Wix Auditorium
12:00-12:15  [INV15] Noam Stern-Ginossar, Weizmann Institute of Science, Israel | Post-transcriptional regulation is critical for controlling innate immune response to infection
The Michael and Anna Wix Auditorium
12:15-12:45  [INV16] Lora Hooper, University of Texas Southwestern Medical Center, USA | The gut microbiome: A master regulator of metabolism
The Michael and Anna Wix Auditorium
12:45-14:15  Lunch
The David Lopatie Conference Centre
14:15-16:00  Session 3: Microbiome in Health & Disease
The Michael and Anna Wix Auditorium
14:15-14:45  [INV17] Brett Finlay, The University of British Columbia, Canada | The role of the microbiota in asthma
The Michael and Anna Wix Auditorium
14:45-15:15  [INV18] Kenya Honda | RIKEN, Japan | Modulation of the immune system by the gut microbiota
The Michael and Anna Wix Auditorium
15:15-15:45  [INV19] Eric Pamer, Memorial Sloan Kettering Cancer Center, USA | Microbiota-mediated defense against intestinal infection
The Michael and Anna Wix Auditorium
15:45-16:00  Dietary influences on the microbiota: New insights thanks to gnotobiology and next-generation sequencing [ST03]
The Michael and Anna Wix Auditorium
16:00-16:30  Refreshment Break
The David Lopatie Conference Centre
16:30-18:15  Session 3: Microbiome in Health & Disease cont.
The Michael and Anna Wix Auditorium
16:30-17:00  [INV20] Michael Fischbach, University of California, San Francisco, USA | Small molecules from the human microbiota
The Michael and Anna Wix Auditorium
17:00-17:15  Longitudinal, single-cell evaluation of the immune state to define the mechanism of B cell depletion therapy in Multiple Sclerosis [ST04]
The Michael and Anna Wix Auditorium
17:15-17:45  [INV21] Philippe Sansonetti, Institüt Pasteur, France | The intestinal crypt: Decrypting a cryptic ecosytem
The Michael and Anna Wix Auditorium
17:45-18:15  [INV22] Richard Flavell, Yale University, USA | Loosely, in the gut with microbes
The Michael and Anna Wix Auditorium
18:15-20:15  Poster session 2
The David Lopatie Conference Centre
18:15-21:30  Drinks Reception and Meet the Speakers Dinner
The David Lopatie Conference Centre
 
Tuesday, 13th February 2018
09:00-10:30  Session 4: Neuro-immune Axis
The Michael and Anna Wix Auditorium
09:00-09:30  [INV23] Vijay Kuchroo, Harvard University, USA | Induction and regulation of Th17 Cells
The Michael and Anna Wix Auditorium
09:30-10:00  [INV24] Dan Littman, New York University, USA | Regulation of T cells by the microbiota
The Michael and Anna Wix Auditorium
10:00-10:30  [INV25] Richard Ransohoff, Harvard Medical School, USA | Microglia: From last-gen to next-gen
The Michael and Anna Wix Auditorium
10:30-11:00  Refreshment Break
The David Lopatie Conference Centre
11:00-12:45  Session 4: Neuro-immune Axis cont.
The Michael and Anna Wix Auditorium
11:00-11:30  [INV26] Michal Schwartz, Weizmann Institute of Science, Israel | Fighting Alzheimer’s disease by unleashing the innate and adaptive immune system
The Michael and Anna Wix Auditorium
11:30-12:00  [INV27] Ana Domingos, Instituto Gulbenkian de Ciência (IGC), Portugal | Sympathetic neuroimmunity for obesity
The Michael and Anna Wix Auditorium
12:00-12:15  IL-17A controls expression of IL-17 lineage cytokines through a negative feedback loop involving IL- 24, and limits autoimmune disease [ST05]
The Michael and Anna Wix Auditorium
12:15-12:45  [INV28] Marco Colonna, Washington University in St Louis, USA | ILC regulomes and Immunoreceptors
The Michael and Anna Wix Auditorium
12:45-14:15  Lunch
The David Lopatie Conference Centre
14:15-16:00  Session 5: Immunity & Metabolism
The Michael and Anna Wix Auditorium
14:15-14:45  [INV29] Ofer Mandelboim, The Hebrew University of Jerusalem, Israel | Human Natural Killer cells remember first pregnancy and better respond in subsequent pregnancies
The Michael and Anna Wix Auditorium
14:45-15:15  [INV30] Jason Cyster, University of California, San Francisco, USA | Oxysterol restraint of cholesterol synthesis prevents AIM2 inflammasome activation
The Michael and Anna Wix Auditorium
15:15-15:45  [INV31] Eran Segal, Weizmann Institute of Science, Israel | Personalizing treatments using microbiome and clinical data
The Michael and Anna Wix Auditorium
15:45-16:00  [INV04] Jakub Abramson, Weizmann Institute of Science, Israel | Quantitative analysis of protein-protein interactions and post-translational modifications in rare immune populations
The Michael and Anna Wix Auditorium
16:00-16:30  Refreshment Break
The David Lopatie Conference Centre
16:30-18:15  Session 5: Immunity & Metabolism cont.
The Michael and Anna Wix Auditorium
16:30-17:00  [INV32] Doreen Cantrell, University of Dundee, UK | Understanding the T cell proteomic landscape: A new discovery tool
The Michael and Anna Wix Auditorium
17:00-17:15  [INV33] Ziv Shulman, Weizmann Institute of Science, Israel | Germinal centers: Arrivals, departures and the T cell border control
The Michael and Anna Wix Auditorium
17:15-17:45  [INV34] Erika Pearce, Max Planck Institute of Immunobiology & Epigenetics, Germany | Mitochondrial priming by CD28
The Michael and Anna Wix Auditorium
17:45-18:15  [INV35] Diane Mathis, Harvard University, USA | Tissue-Treg nurturing-cells
The Michael and Anna Wix Auditorium
18:15-21:30  Dinner and Party in Tel Aviv (transport will be provided)
 
Wednesday, 14th February 2018
09:00-10:30  Session 6: Immunity to Cancer
The Michael and Anna Wix Auditorium
09:00-09:30  [INV36] Alberto Mantovani, Humanitas Clinical and Research Center, Italy | The yin yang of innate immunity and cancer
The Michael and Anna Wix Auditorium
09:30-10:00  [INV37] Padmanee Sharma, MD Anderson Cancer Center, USA | From the clinic to the lab: Investigating response and resistance mechanisms to immune checkpoint therapy
The Michael and Anna Wix Auditorium
10:00-10:15  [INV38] Ravid Straussman, Weizmann Institute of Science, Israel | The tumor microbiome and its effects on chemoresistance
The Michael and Anna Wix Auditorium
10:15-10:30  Innate lymphoid cells and cancer [ST07]
The Michael and Anna Wix Auditorium
10:30-11:00  Refreshment Break
The David Lopatie Conference Centre
11:00-12:40  Session 6: Immunity to Cancer cont.
The Michael and Anna Wix Auditorium
11:00-11:30  [INV39] Guido Kroemer, INSERM, Institut Gustave Roussy, France | Immune-mediated effects of chemopreventive and anticancer agents
The Michael and Anna Wix Auditorium
11:30-12:00  [INV40] Robert Schreiber, Washington University in St Louis, USA | Cancer neoantigens as targets for natural and therapeutic anti-tumor responses
The Michael and Anna Wix Auditorium
12:00-12:40  [INV41] James P. Allison, MD Anderson Cancer Center, USA | Immune checkpoint blockade in cancer therapy: Insights, opportunities, and prospects for cures
The Michael and Anna Wix Auditorium
12:40-13:00  Closing Remarks and End of Meeting
The Michael and Anna Wix Auditorium
 
  Copyright © 2016 Elsevier Limited. Privacy | Terms | Cookies
Powered by Oxford Abstracts. Cookies are set by this site. To decline them or learn more, visit our Cookies page.